By Sean Whooley | September 23, 2025| Pharmaceutical Processing World
Today on Pharmaceutical Processing | Pharmaceutical Processing World
Eli Lilly (NYSE:LLY) announced today that it plans to build a new $6.5 billion manufacturing facility at Generation Park in Houston, Texas. The planned next-generation synthetic medicine active pharmaceutical product (API) facility marks the second of four new sites Lilly plans to announce this year. It follows the announcement of a $5 billion manufacturing facility… The post Lilly to build new $6.5B API manufacturing plant in Texas appeared first on Pharmaceutical Processing World.| Pharmaceutical Processing World
Sai Life Sciences has opened Unit VI, a purpose-built veterinary API facility in Bidar, Karnataka, adjacent to the company’s flagship Unit IV API site. According to the company, the new plant is configured for stringent EHS practices and regulatory readiness to supply animal-health APIs at commercial scale. The unit will support global animal-health customers with… The post Sai Life Sciences opens dedicated veterinary-API unit alongside flagship Bidar site appeared first on Pharmaceutical...| Pharmaceutical Processing World
Eli Lilly (NYSE:LLY) announced today that it plans to build a $5 billion manufacturing facility in Goochland County, Virginia.| Pharmaceutical Processing World
Gilead Sciences (Nasdaq:GILD) announced that it broke ground on its new pharmaceutical development and manufacturing (PDM) technical development center (NTDC) in California. The facility, located at the company’s Foster City headquarters, comes as part of a $32 billion investment in U.S. innovation through 2030. Gilead expects the investment to generate more than $43 billion in… The post Gilead breaks ground on California manufacturing hub appeared first on Pharmaceutical Processing World.| Pharmaceutical Processing World
Thermo Fisher Scientific (NYSE:TMO) announced that it completed its acquisition of a Sanofi facility in New Jersey. The company acquired Sanofi’s state-of-the-art sterile fill-finish and packaging site in Ridgefield, New Jersey. In July, the company announced its plans to acquire this site and continue producing a portfolio of Sanofi therapies there while opening the facility… The post Thermo Fisher completes acquisition of Sanofi’s fill-finish, packaging site in New Jersey appeared fir...| Pharmaceutical Processing World
Grundfos Industry Experts A leading global pharmaceutical manufacturing company, ranked among the top 20 worldwide, sought to optimize operational efficiencies by decreasing costly downtime that was impacting its entire supply chain. Unexpected failures of machinery supplying air to Class Grade A & B clean rooms caused significant disruptions to their manufacturing processes. This situation led… The post Digital Transformation in the Pharmaceutical Industry appeared first on Pharmaceutical ...| Pharmaceutical Processing World
Optel Group announced that it acquired Vanguard Robotics, an expert in end-of-line collaborative robot (cobot) automation. The acquisition reinforces Optel’s commitment to pharmaceutical automation as a leader in traceability and supply chain solutions. By integrating Vanguard’s robotics technology, Optel believes it can help pharmaceutical manufacturers address labor constraints. It also expects the deal to enhance… The post Optel acquires Vanguard Robotics to automate pharma productio...| Pharmaceutical Processing World
Roche and its Genentech unit today announced the groundbreaking for its newest U.S. manufacturing site in Holly Springs, North Carolina. Genentech said the development marks the establishment of its first manufacturing facility on the East Coast. It designed the 65,000-square-meter facility to support the production of its future portfolio of metabolic medicines. Those include next-generation… The post Roche’s Genentech breaks ground on U.S. manufacturing facility appeared first on Pharma...| Pharmaceutical Processing World
Cambrex announced today that it expanded its active pharmaceutical ingredient (API) facility in Waltham, Massachusetts.| Pharmaceutical Processing World
Johnson & Johnson (NYSE:JNJ) announced today that it plans to increase its biopharmaceutical manufacturing presence in North Carolina. The company committed $2 billion toward a 160,000+-square-foot dedicated manufacturing facility at Fujifilm’s new biopharmaceutical manufacturing site in Holly Springs, North Carolina. Its commitment spans the next 10 years, expanding its U.S. manufacturing capacity and creating approximately… The post Johnson & Johnson commits $2B investment to North Caro...| Pharmaceutical Processing World
Eli Lilly (NYSE:LLY) announced today that it made a $4.5 billion investment to create the Lilly Medicine Foundry in Indiana.| Pharmaceutical Processing World
Eli Lilly's investment in capital expansion across therapeutic areas in the U.S. now totals more than $50 billion since 2020.| Pharmaceutical Processing World
Purdue University, Eli Lilly and Merck have launched the Young Institute Pharmaceutical Manufacturing Consortium.| Pharmaceutical Processing World